Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Exec appointment
confidence 95%
filed 2026-06-12
The filing discloses the appointment of David A. Holmes as President and Chief Executive Officer effective June 12, 2026, following the removal of Kevin Mills from that role on June 8, 2026. While both a departure and appointment occur, the principal disclosed action centers on the appointment of the new CEO with detailed biographical information and compensation terms. This is a material executive change affecting the registrant's leadership.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-12
Item 5.02
The disclosure centers on the Board's appointment of Christiane Pendarvis as a new director, effective July 2, 2026, increasing the Board size from eight to nine members. While the section also mentions her eligibility for standard non-employee director compensation, the principal disclosed action is her appointment to the Board, making this an exec_appointment event. The appointment of a qualified independent director with significant retail and consumer business experience is material to investors' assessment of the company's governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-12
Item 5.02
Jason Robins was appointed as Chief Financial Officer, effective June 10, 2026. The appointment represents a material change in the company's financial leadership.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-12
Item 5.02
The disclosure centers on the appointment of Robert Stefani as Manager, Secretary and Treasurer of Empire District Bondco, LLC effective June 10, 2026. While Fraser McNamee's departure is also mentioned, the substantive focus is on Stefani's appointment to the executive role, with detailed background on his prior experience as CFO at Algonquin (the indirect parent), Southwest Gas Holdings, and PECO Energy. The appointment of a new manager and treasurer to a company is material to investors assessing the registrant's governance and leadership.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-12
Item 5.02
The filing discloses the appointment of David Justin Haley as Chief Executive Officer of Medallion Bank effective July 1, 2026, succeeding Donald Poulton. While Poulton's retirement as CEO is also mentioned, the principal action disclosed is Haley's appointment to the CEO role. CEO succession is material to investors as it affects leadership and strategic direction of the registrant.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-06-12
Item 5.02
The disclosure centers on the appointment of J. Colby Williams as Executive Vice President and General Counsel effective September 8, 2026, with detailed terms of his employment agreement including a $1.2M base salary, bonus structure, and equity awards. While Jeffrey T. Welch's retirement as Chief Legal Officer is also disclosed, the substantive focus and length of the filing emphasizes Williams' appointment and compensation terms, making exec_appointment the primary event. The appointment of a senior legal officer with a five-year fixed term and significant equity grants is material to investors.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 94%
filed 2026-06-12
Item 5.02
BrightSpring Health Services appointed Dr. Nigam H. Shah to its Board of Directors as a Class III director, increasing board size from 7 to 8 members and assigning him to the Quality and Compliance Committee.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-12
Item 5.02
The filing discloses both a director departure (Andrew Broderick's resignation effective June 15, 2026) and a director appointment (Barron Steele appointed as Class II director on June 9, 2026). The principal disclosed action centers on the appointment of Steele to fill the vacancy, with detailed disclosure of his compensation (annual cash of $100,000 and initial RSU award of $160,000 prorated), committee assignments, and background. While both events occur, the appointment is the substantive forward-looking action and receives the greater narrative focus.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-12
Item 5.02
Seven directors were appointed to ERock's Board of Directors effective June 9, 2026: Charles Boynton, Dan Brouillette, Hans Kobler, Lindsay Luger, Mark Patterson, Sameer Reddy, and Tony Satterthwaite. The appointments occurred in connection with the effectiveness of the Registration Statement and represent a significant governance event for the newly public company.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-06-12
The 6-K discloses the appointment of two independent directors: Mr. Lau Yun Chau (appointed June 10, 2026, with prior service ending February 2026) and Mr. Lau Chun (appointed June 10, 2026). Both appointments are effective immediately and include director compensation arrangements. The principal disclosed action is the taking of director roles by named individuals, which is the hallmark of exec_appointment. While one director previously served and resigned, the current disclosure emphasizes the new appointments, not departures.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-12
Item 5.02
The filing discloses the appointment of Eric Kilinsky as Interim Chief Financial Officer effective June 8, 2026, with detailed background, qualifications, and a compensation arrangement of $4,000 monthly. While the section also mentions Ofek Haim Suchard's transition from Interim CFO to Chief AI Officer, the principal disclosed action centers on filling the critical CFO role. This is material as it addresses a key officer position responsible for financial oversight and SEC reporting.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-12
Item 5.02
The disclosure centers on the appointment of Heather Birmingham as Chief Compliance Officer, effective June 15, 2026, with detailed background on her 25 years of investment industry experience and prior compliance roles. While Frank Galea's retirement is mentioned, the principal action disclosed is the appointment of a new officer to a material compliance function. The appointment of a Chief Compliance Officer is material to investors assessing the registrant's governance and regulatory oversight.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-06-12
The filing discloses two distinct events under Item 5.02 and Item 5.07. The most salient event is the appointment of Brian Cherry as a Class I director and Audit Committee member effective June 11, 2026, with an initial equity award of 24,000 RSUs vesting over three years. While the filing also reports shareholder vote results (Item 5.07), the appointment of a new board member is the primary material action disclosed and represents a change in the company's governance structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-12
Item 5.02
Three directors—Marco Carrai, Paul Chellgren, and George Muñoz—were appointed to the board in connection with the IPO on June 8, 2026, and assigned to board committees.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-12
Item 5.02
JAB Acquisition Corp I appointed three independent directors—Luisa Ingargiola, Kyle Miller, and David Pfeffer—to the board of directors in connection with the company's IPO on June 11, 2026.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-12
Item 5.02
The filing discloses the election of David Hult as a director of OPENLANE, Inc., effective June 12, 2026, following a Board decision on June 9, 2026 to increase the Board size to ten directors. This is a clear executive appointment event. Mr. Hult brings significant automotive industry experience, having recently served as Executive Chairman of Asbury Automotive Group (NYSE: ABG) and previously as President and CEO of that company. The appointment of a seasoned executive to the Board is material to investors assessing the Company's governance and strategic direction.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-06-12
Item 5.02
The filing discloses Voin Todorovic's promotion to the additional role of Chief Administrative Officer effective June 11, 2026, while continuing as Chief Financial Officer. Although the disclosure also includes compensatory arrangements (base salary of $500,000 and target bonus of 70% of base pay), the principal action is the appointment to a new executive role. The promotion of an existing CFO to dual CFO/CAO responsibilities is material to investors assessing executive leadership structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-12
Item 5.02
Three directors—Pok Yu Chow, Hiu Man Cheng, and Hin Wing Wong—were appointed to the Board on May 4, 2026 in connection with the IPO and subsequently appointed to the Audit and Compensation Committees effective June 10, 2026, establishing the governance structure of the newly public company.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-12
Item 5.02
Michael Bondurant was appointed as Chief Operating Officer, effective June 8, 2026. The appointment also includes compensatory arrangements for Bondurant and Brady Cobb (base salary, performance bonuses, and stock option grants) and adoption of an RSU Plan.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-12
Item 5.02
The filing discloses the appointment of Collin Gallagher to the Board as a Class III director effective June 12, 2026, designated by Thoma Bravo pursuant to a Director Designation Agreement. While the section also mentions Nabil Hamade's resignation, the principal disclosed action centers on the appointment of a new director to fill the vacancy. Board composition changes are material to investors assessing corporate governance and control.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-11
Item 5.02
The disclosure centers on the Board's election of Judson Althoff to the Board of Directors, effective June 24, 2026. This is a clear appointment of a director to the registrant's board. While the section also mentions his participation in the standard independent director compensation program, the principal disclosed action is the appointment itself, not a compensatory arrangement unique to Mr. Althoff. Board composition changes are material to investors.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-06-11
Item 5.02
The filing discloses both the retirement of Russell R. Shaller as President and CEO and the appointment of Vineet Nargolwala as President and CEO, effective June 8, 2026. While both events are disclosed, the principal action emphasized is Nargolwala's appointment to the top executive role, supported by detailed compensation terms ($1M base salary, $6.4M annual stock award, severance provisions, and change-of-control protections). The appointment of a new CEO is material to investors and represents the primary disclosed event, though the departure of the prior CEO is also significant.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-11
Item 5.02
The filing discloses the appointment of Matthew Bradford White as Chief Legal Officer effective June 8, 2026. While the section also details compensatory arrangements (base salary of $500,000, performance bonus, RSUs, signing bonus, and retention bonus), the principal disclosed action is the appointment of a named executive officer to a material position. The compensation details are ancillary to the appointment itself.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-11
Item 5.02
Steven Day was appointed as interim Chief Financial Officer of Adobe effective immediately, following the resignation of Daniel Durn as CFO effective June 15, 2026. Day has been with the company since 2006 and brings substantial prior experience in financial leadership roles.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 94%
filed 2026-06-11
Item 5.02
The Board appointed John C. Fortson as Executive Vice President & Chief Financial Officer, effective July 20, 2026, with a base salary of $780,000, target bonus of 85%, sign-on payments, and equity awards. This represents a material change in senior leadership responsible for financial management and reporting.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-11
Item 5.02
Kenneth Escoe was elected to the Board of Directors of Ingredion Inc. effective July 1, 2026. This is a director appointment disclosed under Item 5.02(d). While the disclosure includes standard compensation details for non-management directors (cash retainer and restricted stock units), the principal action is the appointment of a new director, making exec_appointment the most salient classification. Board composition changes are material to investors.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-11
Item 5.02
Aaron Schutt was appointed Chief Executive Officer of Alaska Silver Corp. effective October 1, 2026, with a comprehensive employment agreement including base salary of $300,000, bonus structure up to 70% of base, 500,000 stock options, and severance provisions. Christopher Marrs departed as President and CEO in connection with this transition.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-11
Item 5.02
Paul F. De Cock was appointed Chief Executive Officer and Director of Mohawk Industries, effective September 30, 2026, succeeding retiring CEO Jeffrey S. Lorberbaum. The appointment includes a base salary of $1,267,000, bonus structure, and an equity award of 30,000 RSUs, representing a material executive transition.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-11
Item 5.02
The filing discloses the election of Tiffany To as a member of the Board of Directors on June 5, 2026. While the disclosure includes compensation details (annual base retainer of $107,500 and a one-time equity grant of $177,500 in restricted stock units), the principal action is the appointment of a new director to the Board. This is a material event affecting the composition of the company's governance and is appropriately classified as an executive appointment.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-11
Item 8.01
Mohamed Genead, M.D., M.Sc., was appointed as Chief Medical Officer of Ocugen effective June 11, 2026, following his service as Acting/Interim Chief Medical Officer since May 8, 2026.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 93%
filed 2026-06-11
Item 5.02
Ms. Jehna Silva was appointed as a director of Farmers & Merchants Bancorp effective June 8, 2026, and assigned to three board committees (CRA, Budget and Finance, and ALCO). The appointment is material due to its impact on board composition and governance structure, and notably involves a family relationship with CEO Kent Steinwert that is relevant to investors assessing board independence.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-11
Item 5.02
The filing discloses the appointment of Kevin J. Necas, Jr. as Senior Vice President – Chief Accounting Officer and principal accounting officer effective July 2, 2026. While Michael P. Gallagher's retirement is also mentioned, the principal disclosed action centers on the appointment of Necas to a key financial officer role. The appointment of a principal accounting officer is material to investors as it affects the registrant's financial reporting oversight and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-11
Item 5.02
Daniel Durn was appointed as Chief Financial Officer and Executive Vice President of Marvell Technology effective June 15, 2026, with a compensation package including $850,000 base salary, $1,000,000 sign-on bonus, and approximately 103,508 RSUs in equity grants.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-11
Item 5.02
The Board approved the appointment of Yiftach Kleinman as Chief Executive Officer, effective no later than September 8, 2026, with a base salary of NIS 80,000/month, bonus structure, and an equity grant of 53,600 options. Mr. Balucka was relieved from the CEO role as part of this leadership transition.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-11
Item 5.02
Matt Davidson, Ph.D. was appointed as Chief Development Officer and Class I Director, and Wendy B. Young, Ph.D. was appointed as Class III Director, both effective immediately upon closing of the Azora merger on June 11, 2026.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-11
Item 5.02
The filing discloses the appointment of Roy Cohen as Chief Financial Officer, effective June 1, 2026. The principal action is a person taking a role—a named executive officer position. While compensation terms are disclosed (NIS 55,000–65,000 per month), the core event is the appointment itself, not a compensation arrangement. CFO appointments are material to investors as they affect financial reporting oversight and corporate governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-11
The filing discloses the appointment of Mr. Theocharis Vasilakis as Chief Technology Officer of Elvictor Group, Inc., effective June 11, 2026, with direct reporting to the CEO and responsibility for technology strategy, digital transformation, AI/ML infrastructure, and software engineering operations. This is a material executive appointment under Item 5.02, as the CTO role is a senior officer position with significant operational responsibilities.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-11
Item 5.02
Keith Wyness and Robert Warfield were appointed to the board of directors effective June 9, 2026, and Grinberg, Wyness, and Warfield were appointed to three board committees (Audit, Compensation, and Corporate Governance and Nominating) with specified chair roles in connection with the company's IPO.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-11
Item 5.02
Following the change of control, new executive leadership was appointed effective June 5, 2026: Elmurod Sopiev as CEO, Temur Zokirov as Chairman/CFO/Secretary, and two independent directors (Bahtiyor Kadirov and Elina Davidyan). Three prior executives (Viktor Balan, Alarcon Martinez Marcelo Ramon, and Anna Toczko) resigned in connection with the transaction.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-11
Item 5.02
Zach Sawtelle was appointed Chief Operating Officer effective June 10, 2026, and designated Chief Executive Officer effective January 1, 2027, succeeding retiring CEO Elias J. Sabo. This executive succession is material to investors' assessment of the company's leadership and strategic direction.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-11
Item 5.02
The filing discloses both a director resignation (Irwin Katsof) and a director appointment (William Conkling). While both events are present, the substantive focus and detail center on the appointment of Conkling, including his extensive background in pharmaceutical commercialization, his independence determination, and his committee assignments (Audit Committee Chair and Financial Expert). The resignation is noted as non-contentious and receives minimal disclosure. Director appointments are material to investors assessing board composition and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-11
Item 5.02
The filing discloses multiple executive appointments on June 9, 2026: Zhao Ling as CEO, Yang Fuzhu as Chairman, Zhang Wenmin as CFO, and four independent directors. While two departures also occurred (Chen Yuanhang as CEO and Wei Zurui as CFO/director), the dominant narrative and bulk of disclosure focuses on the new appointments with detailed biographical information for each appointee. This is a material leadership transition affecting the company's governance structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-06-11
The filing's primary substantive disclosure under Item 5.02 is the appointment of Jordan Zwick to the Board of Directors on June 10, 2026, expanding the Board from five to six directors. While the filing also covers shareholder vote results (Item 5.07) and equity plan amendments, the appointment of a new director with Audit Committee assignment is the most salient executive personnel action disclosed and would be material to investors assessing board composition and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-11
Item 5.02
Eric Park was appointed Chief Accounting Officer effective June 8, 2026, assuming the role of principal accounting officer. While the disclosure also includes compensatory arrangements (base salary increase to $300,000, bonus target of $200,000, and a $175,000 PRSU award), the principal disclosed action is the appointment itself. The appointment of a principal accounting officer is material to investors as it affects the registrant's financial reporting oversight and governance structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-11
Item 5.02
The Board appointed three new independent directors—Robert Fotheringham, Zhenlong Jiao, and Henoc Muamba—on June 9, 2026, expanding the Board from three to six members. The new directors were assigned to lead key committees (Audit, Compensation, and Nominating and Corporate Governance), materially strengthening the company's governance structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-11
Item 5.02
The filing discloses the appointment of two new officers effective June 1, 2026: Andrew MacLeod as Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) and Robert Givens as Secretary. While the section also includes Michael Ssebugwawo's resignation from CFO and other officer roles, the principal disclosed action centers on filling those critical positions with new appointees. The appointments of a CFO and Secretary are material to investors' assessment of the company's governance and financial reporting structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-11
Item 7.01
The filing discloses the appointment of Ms. Craig to the Board of Directors via press release issued on June 11, 2026. Board appointments are material events affecting the composition and governance of the registrant and would inform a reasonable investor's assessment of the company's leadership and oversight structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-10
Item 5.02
Colin M. Adams was elected as a director of Sleep Number's Board effective immediately on June 4, 2026, increasing the Board to 7 members with 6 independent directors. This is a clear executive appointment event. While the disclosure also mentions his compensation arrangement ($40,000 monthly fee), the principal action disclosed is the appointment itself, not a compensation arrangement modification.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 90%
filed 2026-06-10
Item 5.02
Joseph Billante was elected and appointed as Chief Financial Officer effective July 27, 2026, succeeding retiring CFO Jay D. Martin. The disclosure includes Billante's background and compensation package as part of the appointment.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-10
Item 5.02
The filing discloses the Board's appointment of Anthony Vang as the Company's full-time Chief Financial Officer effective June 5, 2026. Although Mr. Vang has performed CFO duties since inception, the formal appointment to the CFO title is the principal disclosed action. This is material as it represents a formal governance change and clarifies the CFO role structure ahead of the Company's Nasdaq uplisting application.
View raw filing on EDGAR →